# Safety, Tolerability and Efficacy of MK0773 in Healthy Postmenopausal Women (0773-003)

> **NCT01011725** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 67 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** MK 0773
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01011725
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2006-04
- **Final completion:** 2009-03
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2016-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01011725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01011725, "Safety, Tolerability and Efficacy of MK0773 in Healthy Postmenopausal Women (0773-003)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01011725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*